Form 8-K - Current report:
SEC Accession No. 0001683168-24-005844
Filing Date
2024-08-16
Accepted
2024-08-16 16:56:50
Documents
18
Period of Report
2024-08-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT acon_8k-exchange.htm   iXBRL 8-K 49661
2 SERIES B CONVERTIBLE PREFERRED STOCK CERTIFICATE OF DESIGNATIONS DATED AUGUST 14 acon_ex0301.htm EX-3.1 349903
3 FORM OF EXCHANGE AGREEMENT DATED AUGUST 14, 2024 acon_ex1001.htm EX-10.1 195073
8 GRAPHIC image_001.jpg GRAPHIC 4500
9 GRAPHIC image_002.jpg GRAPHIC 3755
  Complete submission text file 0001683168-24-005844.txt   959959

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE acon-20240814.xsd EX-101.SCH 3788
5 XBRL DEFINITION FILE acon-20240814_def.xml EX-101.DEF 26648
6 XBRL LABEL FILE acon-20240814_lab.xml EX-101.LAB 36765
7 XBRL PRESENTATION FILE acon-20240814_pre.xml EX-101.PRE 25272
20 EXTRACTED XBRL INSTANCE DOCUMENT acon_8k-exchange_htm.xml XML 5794
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Filer) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41358 | Film No.: 241217363
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)